Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 6 papers. Top paper: “FDA Approval Summary: Idecabtagene Vicleucel for Relapsed or Refractory Multiple Myeloma”.
Bindu Kanapuru, Bindu George, Xue Lin, Zhenzhen Xu, Wilson W. Bryan +3 more
Xia Ge, Mary Brummet, Xue Lin, David D. Timm, A Davignon +9 more
Xue Lin, Lu-Jing Zhang, Li Chen, Yongpeng Sun, Jun-Yu Si +7 more
Praveen Krishnamoorthy, Emma C. Walker, Hemant Joshi, Sharon Celeste Morley, Xue Lin
Xue Lin, Zhiyong Li, Lu-Jing Zhang, Li Chen, Yongpeng Sun +10 more
Sarah Javati, Elizabeth M. Todd, John-Paul Matlam, Xue Lin, Michelle K. Bryant +25 more